Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-26T04:24:18.803Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of a patient suffering from schizophrenia and Becker muscular dystrophy with clozapine

Published online by Cambridge University Press:  24 June 2014

Riccardo N. Caniato ,
Anand Gundaberwady ,
Amol Deshmuck ,
Miguel Angel Garcia-Alcaraz  and
Bernhard T. Baune
Riccardo N. Caniato*
Affiliation:
Department of Psychiatry, School of Medicine, James Cook University, Townsville, Queensland, Australia Institute of Mental Health Services, The Townsville Hospital, Townsville, Queensland, Australia
Anand Gundaberwady
Affiliation:
Institute of Mental Health Services, The Townsville Hospital, Townsville, Queensland, Australia
Amol Deshmuck
Affiliation:
Institute of Mental Health Services, The Townsville Hospital, Townsville, Queensland, Australia
Miguel Angel Garcia-Alcaraz
Affiliation:
Department of Psychiatry, School of Medicine, James Cook University, Townsville, Queensland, Australia Institute of Mental Health Services, The Townsville Hospital, Townsville, Queensland, Australia
Bernhard T. Baune
Affiliation:
Department of Psychiatry, School of Medicine, James Cook University, Townsville, Queensland, Australia
*
Dr Riccardo N. Caniato Department of Psychiatry, School of Medicine, James Cook University, Townsville Queensland, Australia Tel: 61 07 47963880; Fax: 61 07 47963881; E-mail: riccardo_caniato@health.qld.gov.au
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 20 , Issue 3 , June 2008 , pp. 172 - 173
Copyright
Copyright © 2008 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kunkel, LM, Hejtmancik, JF, Caskey CT Speer, Aet al. Analysis of deletions in DNA in participants with Becker and Duchenne muscular dystrophy. Nature 1986;322:73–77. CrossRefGoogle Scholar
American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005;116:1569–1573. CrossRefGoogle ScholarPubMed
Emery, AE, Skinner, R. Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 1976;10:189–201. CrossRefGoogle ScholarPubMed
Reinders, J, Parsonage, W, Lange, D, Potter, JM, Plever, S. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Aust N Z J Psychiatry 2004;38:915–922. CrossRefGoogle Scholar
Koren, W, Koren, E, Nacasch, N, Ehrenfeld, M, Gur, H. Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium-dependent potassium permeability of cell membranes. Clin Neuropharmacol 1998;21:262–264. Google Scholar
Galletly, C. Subjective muscle weakness and hypotonia during clozapine treatment. Ann Clin Psychiatry 1996;8:189–192. CrossRefGoogle ScholarPubMed
Abe, M, Aria, M, Mahera, K, Arikawa, E, Arahata, K. A case of becker muscular dystropy with schizophrenic symptoms. No To Shinkei 1990;42:1061–1066. Google Scholar
Zatz, M, Vallada, H, Melo, MSet al. Cosegregation of schizophrenia with Becker muscular dystrophy: a susceptibility locus for schizophrenia at Xp21 or an effect of the dystrophin gene in the brain? J Med Genet 1993;30:131–134. CrossRefGoogle ScholarPubMed
Melo, M, Vierira, AH, Passos-Bueno, MR, Zatz, M. Association of schizophrenia and Duchenne muscular dystrophy. Br J Psychiatry 1993;162:711–712. CrossRefGoogle ScholarPubMed
Kane, J, Honigfeld, G, Singer, J, Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789–796. CrossRefGoogle ScholarPubMed
Reinders, J, Parsonage, W, Lange, D, Potter, JM, Pleaver, S. Clozapine-related myocarditis in an Australian metropolitan service. Aust N Z J Psychiatry 2004;38:915–922. CrossRefGoogle Scholar
Caniato, RN, Alvarenga, ME, Garcia-Alcarez, MA. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine. Aust N Z J Psychiatry 2007;40:691–697. CrossRefGoogle ScholarPubMed
Galletly, C. Subjective muscle weakness and hypotonia during clozapine treatment. Ann Clin Psychiatry 1996;8;189–192. CrossRefGoogle ScholarPubMed